tafenoquine has been researched along with phenylbutazone in 1 studies
| Studies (tafenoquine) | Trials (tafenoquine) | Recent Studies (post-2010) (tafenoquine) | Studies (phenylbutazone) | Trials (phenylbutazone) | Recent Studies (post-2010) (phenylbutazone) |
|---|---|---|---|---|---|
| 186 | 37 | 113 | 6,291 | 317 | 125 |
| Protein | Taxonomy | tafenoquine (IC50) | phenylbutazone (IC50) |
|---|---|---|---|
| fMet-Leu-Phe receptor | Homo sapiens (human) | 5.3 | |
| Cyclooxygenase-2 | Canis lupus familiaris (dog) | 3.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for tafenoquine and phenylbutazone
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |